Lexis follows a strict anti-plagiarism policy to ensure high-quality scientific publications, public trust in scientific findings, high impact and citations. Lexis accepts all terms and conditions of COPE about plagiarism. All cases of plagiarism dealt in accordance with the COPE policies. Lexis is committed in publishing only original material, i.e., material that has neither been published elsewhere, nor is under review by any other publisher.
Manuscripts that are found to have been published elsewhere or are under consideration in any other journal will be treated as a duplicate submission. If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they are required to cite the previous work and indicate how their submitted manuscript offers novel contributions beyond those of the previous work.
Submitted manuscripts that are found to include citations whose primary aim is to increase the number of citations to a given author’s work, or to articles published in a particular journal, will be treated as citation manipulation and will be dealt in accordance with the publication policies as recommended by ICMJE and COPE.
Submitted manuscripts that are found to have either fabricated or falsified experimental results, including the manipulation of images, will be treated as data fabrication and falsification. All authors are requested to read submissions guidelines carefully before submission.
All listed authors must have made a significant scientific contribution to the research in the manuscript and approved all its claims. It is important to list everyone who made a significant scientific contribution, including design, study, supervision. Kindly consult the authorship criteria as recommended by ICMJE.
Redundant publications involve the inappropriate division of study outcomes into several articles. All authors are requested to read submissions guidelines carefully before submission.